Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer
| 适应症 | Lung Cancer |
|---|---|
| 分期 | 不适用 |
| 申办方 | Massachusetts General Hospital |
| 状态 | 已完成 |
| 受试者人数 | 507 人 |
| 干预（药物） | Stepped PC, Early Integrated PC |
| 开始日期 | 2018年2月1日 |
| 完成日期 | 2023年7月1日 |
| 结果公布日 | 2024年9月3日 |
摘要
This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer
Patient-reported Quality of Life
| Stepped PC | 100.62 score on a scale |
|---|---|
| Early Integrated PC | 97.75 score on a scale |
| p-value | <0.05 |
|---|---|
| Mean Difference (Final Values) | 2.9 |
在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文
同一适应症的其他试验
- Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer — M.D. Anderson Cancer Center
- Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tum — National Cancer Institute (NCI)
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients W — National Cancer Institute (NCI)
- A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients W — AstraZeneca
- Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therap — National Cancer Institute (NCI)
- Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With — National Cancer Institute (NCI)